Dupuytren's Disease
Conditions
Keywords
Dupuytren's Contracture
Brief summary
A study to validate two newly developed questionnaires for Dupuytren's Disease. The objective is to develop a patient specific outcomes tool for Dupuytren's Disease. While there are standard and validated questionnaire instruments used to measure health related quality of life and function, they do not address patient specific issues. The investigators will also pilot a treatment/disease specific satisfaction questionnaire for Xiaflex use for Dupuytren's Disease.
Interventions
None listed
Sponsors
Auxilium Pharmaceuticals, Inc.
Robert Hotchkiss
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subject has a diagnosis of Dupuytren's Disease in at least one finger * Patients will be 35 years of age or older * Patients will be able to read, speak, and understand English * Patients will be able to provide voluntary written consent to participate
Exclusion criteria
* Female patients who are nursing or pregnant, or plan to become pregnant during the treatment phase. * Patient has a chronic muscular, neurological or neuromuscular disorder that affects the hands. * Patient has a known allergy to collagenase or any other excipient of XIAFLEX. * Patient has received any collagenase treatments before the first dose of XIAFLEX. * Any history of or current medical condition which in the investigator's opinion would make the subject unsuitable for enrollment in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QuickDASH (Disability of the Arm, Shoulder, and Hand) | 30 day follow up |
Countries
United States
Outcome results
None listed